Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01856933
What this trial is testing

BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)

Who this might be right for
GBMGlioblastoma MultiformeGliosarcoma
Heinrich Elinzano, MD 6
Testing effectiveness (Phase 2)Study completedNCT00003301
What this trial is testing

Irinotecan in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Testing effectiveness (Phase 2)Looking for participantsNCT05465954
What this trial is testing

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

Who this might be right for
High Grade Astrocytic TumorRecurrent Glioblastoma, IDH-WildtypeRecurrent Gliosarcoma
Mayo Clinic 54
Testing effectiveness (Phase 2)Study completedNCT00619112
What this trial is testing

Temozolomide in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Recurrent Central Nervous System Neoplasm
University of California, San Francisco 60
Large-scale testing (Phase 3)Study completedNCT00118222
What this trial is testing

High Light and Low Light Dose PDT in Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Case Comprehensive Cancer Center 1
Early research (Phase 1)Study completedNCT00003463
What this trial is testing

Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Not applicableUnknownNCT05811793
What this trial is testing

Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.

Who this might be right for
Glioblastoma
Second Affiliated Hospital of Nanchang University 36
Testing effectiveness (Phase 2)WithdrawnNCT04118036
What this trial is testing

Abemaciclib + Pembrolizumab In Glioblastoma

Who this might be right for
Glioblastoma
Dana-Farber Cancer Institute
Early research (Phase 1)Looking for participantsNCT06186401
What this trial is testing

Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

Who this might be right for
EGFR Gene MutationGlioblastomaMGMT-Unmethylated Glioblastoma+1 more
Hideho Okada, MD, PhD 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06061809
What this trial is testing

N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma

Who this might be right for
Glioblastoma
ImmunityBio, Inc. 34
Testing effectiveness (Phase 2)Looking for participantsNCT06011109
What this trial is testing

Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab

Who this might be right for
GliomaGlioblastoma Multiforme
Aveta Biomics, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00003775
What this trial is testing

Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse

Who this might be right for
Brain and Central Nervous System Tumors
Pfizer 60
Testing effectiveness (Phase 2)Ended earlyNCT04469699
What this trial is testing

Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme, Adult
University Hospital Muenster 30
Testing effectiveness (Phase 2)Study completedNCT00014300
What this trial is testing

Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 32
Early research (Phase 1)Looking for participantsNCT05283330
What this trial is testing

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Who this might be right for
Cervical CancerBreast CancerColon Cancer+4 more
Orano Med Theranostics, SAS 48
Early research (Phase 1)Ended earlyNCT00006773
What this trial is testing

Bortezomib in Treating Patients With Recurrent Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT01268566
What this trial is testing

MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
MedImmune LLC 62
Early research (Phase 1)Looking for participantsNCT04903795
What this trial is testing

BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma

Who this might be right for
Newly Diagnosed GlioblastomaRecurrent Glioblastoma
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 18
Testing effectiveness (Phase 2)Study completedNCT00107237
What this trial is testing

AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Novartis Pharmaceuticals 16
Not applicableUnknownNCT00392548
What this trial is testing

URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol

Who this might be right for
Glioblastoma
Tel-Aviv Sourasky Medical Center 130
Next Page